Outcome of acute myeloid leukemia patients with hyperleukocytosis in Brazil

Medical Oncology

Volumn 27, Issue 4, 2010, Pages 1254-1259

  Oliveira, L C O ^a   Romano, L G M ^a   Prado Junior, B P A ^a   Covas, D T ^a   Rego, E M ^a   De Santis, G C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Acute myeloid leukemia; Early death; Hyperleukocytosis

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; BRAZIL; CREATININE BLOOD LEVEL; DISEASE COURSE; FEMALE; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOCYTE COUNT; LEUKOCYTOSIS; LEUKOSTASIS; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME; UREA NITROGEN BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAZIL; CREATININE; FEMALE; FLOW CYTOMETRY; HUMANS; L-LACTATE DEHYDROGENASE; LEUKEMIA, MYELOID, ACUTE; LEUKOCYTE COUNT; LEUKOCYTOSIS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; YOUNG ADULT;

EID: 79951768705     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-009-9367-9     Document Type: Article

References (26)

1. Dutcher JP, Schiffer CA, Wiernik PH. Hyperleukocytosis in adult acute nonlymphocytic leukemia: impact on remission rate and duration, and survival. J Clin Oncol. 1987;5(9):1364-72.
2. Greenwood MJ, Seftel MD, Richardson C, Barbaric D, Barnett MJ, Bruyere H, et al. Leukocyte count as a predictor of death during remission induction in acute myeloid leukemia. Leuk Lymphoma. 2006;47(7):1245-52. (Pubitemid 44269630)
3. Zhang W, Zhang X, Fan X, Li D, Qiao Z. Effect of ICAM-1 and LFA-1 in hyperleukocytic acute myeloid leukaemia. Clin Lab Haematol. 2006;28(3):177-82.
4. Stucki A, Rivier AS, Gikic M, Monai N, Schapira M, Spertini O. Endothelial cell activation by myeloblasts: molecular mechanisms of leukostasis and leukemic cell dissemination. Blood. 2001;97(7):2121-9. (Pubitemid 32239095)
5. Cavenagh JD, Gordon-Smith EC, Gordon MY. The binding of acute myeloid leukemia blast cells to human endothelium. Leuk Lymphoma. 1994;16(1-2): 19-29.
6. Lichtman MA, Rowe JM. Hyperleukocytic leukemias: rheological, clinical, and therapeutic considerations. Blood. 1982;60(2):279-83. (Pubitemid 12048667)
7. Creutzig U, Zimmermann M, Reinhardt D, Dworzak M, Stary J, Lehrnbecher T. Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98. J Clin Oncol. 2004;22(21):4384-93. (Pubitemid 41185159)
8. Porcu P, Cripe LD, Ng EW, Bhatia S, Danielson CM, Orazi A, et al. Hyperleukocytic leukemias and leukostasis: a review of pathophysiology, clinical presentation and management. Leuk Lymphoma. 2000;39(1-2): 1-18. (Pubitemid 30662024)
9. Giles FJ, Shen Y, Kantarjian HM, Korbling MJ, O'Brien S, Anderlini P, et al. Leukapheresis reduces early mortality in patients with acute myeloid leukemia with high white cell counts but does not improve long-term survival. Leuk Lymphoma. 2001;42(1-2): 67-73. (Pubitemid 32700923)
10. Porcu P, Danielson CF, Orazi A, Heerema NA, Gabig TG, McCarthy LJ. Therapeutic leukapheresis in hyperleucocytic leukaemias: lack of correlation between degree of cytoreduction and early mortality rate. Br J Haematol. 1997;98(2):433-6. (Pubitemid 27345121)
11. Fagundes EM, Rocha V, Gloria AB, Clementino NC, Quintao JS, Guimaraes JP, et al. De novo acute myeloid leukemia in adults younger than 60 years of age: socioeconomic aspects and treatment results in a Brazilian university center. Leuk Lymphoma. 2006;47(8):1557-64. (Pubitemid 44364021)
12. Onsten T, Girardi FM, Coelho GM, Lima Frey MC, Paskulin G. Cytogenetic and morphological findings in 166 patients with de novo acute myeloid leukemia in southern Brazil. Cancer Genet Cytogenet. 2006;170(2):167-70. (Pubitemid 44442463)
13. Jacomo RH, Melo RA, Souto FR, de Mattos ER, de Oliveira CT, Fagundes EM, et al. Clinical features and outcomes of 134 Brazilians with acute promyelocytic leukemia who received ATRA and anthracyclines. Haematologica. 2007;92(10):1431-2. (Pubitemid 350144166)
14. Marbello L, Ricci F, Nosari AM, Turrini M, Nador G, Nichelatti M, et al. Outcome of hyperleukocytic adult acute myeloid leukaemia: a single-center retrospective study and review of literature. Leuk Res. 2008;32(8):1221-7.
15. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med. 1985;103(4):620-5.
16. Arber DA, Brunning RD, Orazi A, Bain BJ, Porwit A, Vardiman JW, et al. Acute myeloid leukaemia with myelodysplasia-related changes. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC: Lyon; 2008. p. 124-6.
17. Borowitz MJ, B'n' MC, Harris NL, Porwit A, Matutes E, Swerdlow SH, et al. Acute leukaemias of ambiguous lineage. WHO Classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2008. p. 150-5.
18. Vardiman JW, Arber DA, Brunning RD, Larson RA, Matutes E, Baumann I, et al. Therapy-related myeloid neoplasms. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2008. p. 127-9.
19. Rothe G, Schmitz G. Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies. Working group on flow cytometry and image analysis. Leukemia. 1996;10(5):877-95. (Pubitemid 26168408)
20. Visani G, Bernasconi P, Boni M, Castoldi GL, Ciolli S, Clavio M, et al. The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia-analysis of 848 patients. Leukemia. 2001;15(6):903-9. (Pubitemid 32529889)
21. Wahlin A, Markevarn B, Golovleva I, Nilsson M. Improved outcome in adult acute myeloid leukemia is almost entirely restricted to young patients and associated with stem cell transplantation. Eur J Haematol. 2002;68(1):54-63. (Pubitemid 34407543)
22. Kristinsson SY, Derolf AR, Edgren G, Dickman PW, Bjorkholm M. Socioeconomic differences in patient survival are increasing for acute myeloid leukemia and multiple myeloma in Sweden. J Clin Oncol. 2009;27(12):2073-80.
23. Alcalai R, Ben-Yehuda D, Ronen I, Paltiel O. Ethnicity and prognosis in acute myeloid leukemia. Am J Hematol. 2003;72(2):127-34. (Pubitemid 36164348)
24. Inaba H, Fan Y, Pounds S, Geiger TL, Rubnitz JE, Ribeiro RC, et al. Clinical and biologic features and treatment outcome of children with newly diagnosed acute myeloid leukemia and hyperleukocytosis. Cancer. 2008;113(3):522-9.
25. Lester TJ, Johnson JW, Cuttner J. Pulmonary leukostasis as the single worst prognostic factor in patients with acute myelocytic leukemia and hyperleukocytosis. Am J Med. 1985;79(1):43-8. (Pubitemid 15072945)
26. Thiebaut A, Thomas X, Belhabri A, Anglaret B, Archimbaud E. Impact of pre-induction therapy leukapheresis on treatment outcome in adult acute myelogenous leukemia presenting with hyperleukocytosis. Ann Hematol. 2000;79(9):501-6.